We are live on ! Find out more
CCIA

Campbell & Co Investment Adviser Portfolio holdings

AUM $1.91B
1-Year Est. Return 17.57%
This Fund
S&P 500
This Quarter Est. Return
-4.35%
1 Year Est. Return
+17.57%
3 Year Est. Return
+30.96%
5 Year Est. Return
+33.24%
10 Year Est. Return
+189.91%
AUM
$1.3B
AUM Growth
+$7.71M
Cap. Flow
+$92.4M
Cap. Flow %
7.09%
Top 10 Hldgs %
6.04%
Holding
1,409
New
392
Increased
321
Reduced
279
Closed
417

Top Buys

Rank Stock Value
1
SYF icon
Synchrony
SYF
+$9.84M
2
LH icon
Labcorp
LH
+$8.89M
3
HUBB icon
Hubbell
HUBB
+$7.76M
4
SNY icon
Sanofi
SNY
+$7.7M
5
JHG
Janus Henderson
JHG
+$7.68M

Top Sells

Rank Stock Value
1
ICE icon
Intercontinental Exchange
ICE
+$10.4M
2
FAST icon
Fastenal
FAST
+$10.2M
3
HCA icon
HCA Healthcare
HCA
+$9.44M
4
SCHW
Charles Schwab
SCHW
+$9.09M
5
NVS icon
Novartis
NVS
+$9.01M

Sector Composition

Rank Sector Weight
1 Financials 17%
2 Healthcare 16.16%
3 Consumer Discretionary 11.61%
4 Industrials 11.13%
5 Technology 9.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GTLS
576
DELISTED
Chart Industries
GTLS
$657K 0.05%
+4,548
New +$838K
VTRS icon
577
Viatris
VTRS
$18.5B
$656K 0.05%
75,348
+56,317
+296% +$591K
ZD icon
578
Ziff Davis
ZD
$1.88B
$655K 0.05%
17,431
-1,622
-9% -$77.8K
MEOH icon
579
Methanex
MEOH
$4.17B
$651K 0.05%
+18,566
New +$834K
WLY icon
580
John Wiley & Sons Class A
WLY
$2.53B
$645K 0.05%
14,476
+3,647
+34% +$154K
SRPT icon
581
Sarepta Therapeutics
SRPT
$1.94B
$645K 0.05%
10,105
+6,275
+164% +$661K
CSCO icon
582
Cisco
CSCO
$488B
$641K 0.05%
10,394
-10,020
-49% -$617K
NDSN icon
583
Nordson
NDSN
$17.3B
$640K 0.05%
3,173
-8,387
-73% -$1.78M
EGO icon
584
Eldorado Gold
EGO
$10.4B
$639K 0.05%
+37,990
New +$570K
MFC icon
585
Manulife Financial
MFC
$72.6B
$638K 0.05%
+20,486
New +$619K
EVER icon
586
EverQuote
EVER
$867M
$638K 0.05%
24,357
-7,662
-24% -$175K
EBF icon
587
Ennis
EBF
$556M
$638K 0.05%
31,747
+1,138
+4% +$23.6K
CW icon
588
Curtiss-Wright
CW
$26.7B
$637K 0.05%
+2,008
New +$678K
BNL icon
589
Broadstone Net Lease
BNL
$4.31B
$632K 0.05%
37,109
-44,378
-54% -$720K
TECH icon
590
Bio-Techne
TECH
$11.3B
$631K 0.05%
+10,755
New +$729K
VZ icon
591
Verizon
VZ
$195B
$628K 0.05%
13,836
-55,824
-80% -$2.32M
LW icon
592
Lamb Weston
LW
$7.3B
$627K 0.05%
+11,761
New +$666K
MANH icon
593
Manhattan Associates
MANH
$11.2B
$624K 0.05%
3,604
+1,337
+59% +$278K
LPX icon
594
Louisiana-Pacific
LPX
$5.15B
$623K 0.05%
+6,770
New +$707K
FNKO icon
595
Funko
FNKO
$331M
$622K 0.05%
+90,637
New +$1.05M
IQV icon
596
IQVIA
IQV
$39.8B
$621K 0.05%
+3,523
New +$683K
VIST icon
597
Vista Energy
VIST
$7.32B
$618K 0.05%
13,266
+8,516
+179% +$440K
CPB icon
598
Campbell Soup
CPB
$6.74B
$615K 0.05%
15,413
-98,760
-87% -$3.87M
CTS icon
599
CTS Corp
CTS
$1.82B
$615K 0.05%
14,793
-4,013
-21% -$188K
HLMN icon
600
Hillman Solutions
HLMN
$1.73B
$614K 0.05%
69,883
-9,621
-12% -$93.4K
22 23
24
25 26

Similar funds

BOH
Bank of Hawaii Honolulu, Hawaii $1.91B AUM 22.08% 1-Year Est. Return
MC
Maren Capital Chicago, Illinois $1.91B AUM 17.37% 1-Year Est. Return
FTCM
First Trust Capital Management Chicago, Illinois $1.9B AUM 58.28% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
DCP
Distillate Capital Partners Chicago, Illinois $1.9B AUM 2.22% 1-Year Est. Return
QOP
Quinn Opportunity Partners Charlottesville, Virginia $1.92B AUM 31.26% 1-Year Est. Return
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return
RCAG
Rehmann Capital Advisory Group Lansing, Michigan $1.92B AUM 16.97% 1-Year Est. Return

Campbell & Co Investment Adviser's Q1 2025 Portfolio in Review

As of Q1 2025, Campbell & Co Investment Adviser held 1,409 positions worth $1.3B, up 0.6% from $1.3B the previous quarter. Its ten largest holdings account for 6% of the portfolio.

Campbell & Co Investment Adviser deployed $92.4M of net new capital in Q1 2025, opening 392 new positions and adding to 321 existing holdings. Its largest new stake was Synchrony: 159,080 shares worth $8.42M.

By sector, the portfolio is most concentrated in Financials at 17% of assets, up from 16% a quarter earlier, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was Novartis, an estimated $9.01M trimmed.

  • Campbell & Co Investment Adviser's largest Q1 2025 buy was Synchrony: 159,080 shares worth $8.42M.
  • Campbell & Co Investment Adviser added most to Labcorp in Q1 2025, an estimated $8.89M increase.
  • Campbell & Co Investment Adviser's biggest Q1 2025 reduction was Novartis, cutting an estimated $9.01M.
  • Campbell & Co Investment Adviser fully exited Intercontinental Exchange in Q1 2025, selling an estimated $10.4M.
  • Campbell & Co Investment Adviser's ten largest holdings make up 6% of its $1.3B portfolio in Q1 2025.
  • Campbell & Co Investment Adviser opened 392 new positions and closed 417 in Q1 2025.
  • Campbell & Co Investment Adviser's portfolio value rose 0.6% quarter-over-quarter to $1.3B.

Based on Campbell & Co Investment Adviser's 13F filing for Q1 2025, filed 14 May 2025.